Grid Therapeutics is an emerging biotechnology company located in Durham, North Carolina. Grid’s research and development efforts are in the area of cancer therapeutics, applying an innovative platform to develop...

Grid Therapeutics has the exclusive rights to a novel antibody against a new and unique target for the treatment of lung cancer with applications in multiple cancer types.

Keep yourself updated with the latest news from Grid. Check back regularly for new content posted weekly about cancer treatment and the search for a cure!